Filter
1682
Filtered Results: 1682
Text search:
drug-resistant
TB
Featured
Recommendations
175
New Publications
453
Language
Document type
No document type
1075
Studies & Reports
208
Guidelines
188
Manuals
59
Strategic & Response Plan
50
Situation Updates
42
Fact sheets
31
Training Material
19
Infographics
5
Brochures
2
Online Courses
2
Videos
1
Countries / Regions
India
92
Western and Central Europe
66
South Africa
56
Kenya
54
Eastern Europe
47
Ethiopia
36
Nepal
34
Tanzania
33
Zambia
28
Global
28
Nigeria
27
Uganda
25
Malawi
25
Myanmar / Burma
25
Namibia
23
Africa
21
Ghana
20
Liberia
19
Bangladesh
19
Rwanda
18
Ukraine
18
Sierra Leone
17
Latin America and the Carribbean
17
Asia
17
Cambodia
16
Lesotho
15
South–East Asia Region
13
Philippines
12
Colombia
12
Russia
11
Senegal
10
Mozambique
10
Zimbabwe
9
Indonesia
9
Botswana
9
Pakistan
8
Eswatini/ Swaziland
8
Germany
7
Argentina
7
Tajikistan
7
Congo, Democratic Republic of
6
Venezuela
6
Haiti
5
Peru
5
Cameroon
4
Thailand
4
Brazil
4
El Salvador
4
East and Southern Africa
4
Eastern Europe and Central Asia
4
Paraguay
4
Albania
4
Armenia
4
Burkina Faso
3
South Sudan
3
Syria
3
Sudan
3
Benin
3
Bolivia
3
Western Pacific Region
3
Laos
3
Timor Leste/ East Timor
3
Vietnam
3
Guinea
2
Morocco
2
USA
2
Jordan
2
Papua New Guinea
2
Ecuador
2
Madagascar
2
Sri Lanka
2
West and Central Africa
2
Middle East and North Africa
2
Bhutan
2
Romania
2
Moldova
2
Iran
2
Georgia
2
Uruguay
2
Saudi Arabia
1
Somalia
1
Iraq
1
Afghanistan
1
Lebanon
1
Gambia
1
Central African Republic
1
North Macedonia
1
Switzerland
1
Hungary
1
Honduras
1
Greece
1
Guatemala
1
Mexico
1
Nicaragua
1
Chile
1
Poland
1
North Korea
1
Bulgaria
1
Estonia
1
Gabon
1
Turkmenistan
1
Maldives
1
Tunisia
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
664
Clinical Guidelines
152
Public Health
50
Capacity Building
23
Women & Child Health
23
Key Resources
23
Pharmacy & Technologies
17
Toolboxes
TB
619
AMR
175
HIV
174
Pharmacy
41
Caregiver
23
Refugee
21
Ebola
19
COVID-19
19
Polio
17
NTDs
17
Conflict
15
Global Health Education
15
Mental Health
13
Rapid Response
12
Planetary Health
11
Health Financing Toolbox
10
NCDs
9
Natural Hazards
4
Disability
3
Specific Hazards
2
Social Ethics
2
Cholera
1
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This...
Reports of antimicrobial-resistant (AMR) microorganisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for human immunodefic...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory ...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, and b.) there is a ...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income coun...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug res... Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gram-negative bacteria, such as Klebsiella pneumoniae and Escherichia coli, can cause severe and often deadly infections that pose a particular threat for people with weak or not yet fully developed immune systems, including newborns, ageing populations, people undergoing surgery and cancer treatment.
The report highlights a worrying gap in activity against the highly resistant NDM-1 (New Delhi metallo-beta-lactamase 1), with only three antibiotics in the pipeline. NDM-1 makes bacteria resistant to a broad range of antibiotics, including those from the carbapenem family, which today are the last line of defence against antibiotic-resistant bacterial infections.
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
HIV infection, due to the immunosuppressant that leads, nowadays constitutes an aggravating factor of endemic tuberculosis. Tuberculosis remains a huge burden to human health, even in the early 21st century. The situation is deteriorating in many countries, particularly because of the synergy with t...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul...
Migrants and mobile popul...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
Antimicrobial Resistance and Infection Control 2014,3 :31
South Eastern European Journal of Public Health, EEJPH 2016, posted: 11 January 2016. DOI 10.4119/UNIBI/SEEJPH-2016-85
Emerging Infectious Diseases; Vol. 21, No. 11, November 2015
15. Euro Surveill. 2017;22(47):pii=17-00103
National Tuberculosis and Leprosy Control Program
Research
Emerging Infectious Diseases Vol. 12, No. 5, May 2006
